A Preliminary Drug Drug Interaction Study With TA-8995

NCT02124954 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetic Interactions

Interventions

DRUG: TA-8995
DRUG: Midazolam
DRUG: Digoxin

Sponsor

Xention Ltd